However, in contrast, SCFAs have also shown to be correlated with the expansion of immunosuppressive pro-cancer regulatory CD4+T cells (Treg) and a resistance to anti-cancer immune-checkpoint inhibitor therapy [47]. This evidence concerns the gene CD4 and cancer.